WILMINGTON, Del., Aug. 4, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq:NRXP), a clinical-stage biopharmaceutical company, today announced the filing of a Citizen Petition with the US Food ...
LOS ANGELES, CA - August 25, 2025 (NEWMEDIAWIRE) - NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, has submitted a formal Citizen Petition to the U.S. Food and Drug ...
Pursues Dual Pathway For Preservative-Free Ketamine-Based Therapies. <li /> The company has refiled its Abbreviated New Drug Application (“ANDA”) for KETAFREE(TM), a preservative-free IV ketamine ...
$NRXP Has $7.8 Million for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal ...
"We finalized the FDA's previous determination that 28 active ingredients, including triclosan and benzethonium chloride, are not eligible for evaluation under the FDA's OTC Drug Review for use in ...